2018-02-01 |
1 |
|
Patent”); 8,476,284 (“the ’284 Patent”); 8,754,090 (“the ’090
Case 1:18-cv-00192-CFC Document 1 Filed… United States Patent Nos. 8,008,309 (“the ’309 Patent”); 7,514,444 (“the ’444
Patent”); 8,697,711 (“…(“the ’711 Patent”); 8,735,403 (“the ’403 Patent”); 8,957,079 (“the ’079
Patent”); 9,181,257 (“the ’257…’257 Patent”); 8,754,091 (“the ’091 Patent”); 8,497,277 (“the ’277
Patent”); 8,952,015 (“the ’015 Patent…37 PageID #: 2
Patent”); 9,296,753 (“the ’753 Patent”); 9,725,455 (“the ’455 Patent”); 9,540,382 (“the |
External link to document |
2019-02-14 |
104 |
|
B2 ;9,801,881 B2 ;9,801,883 B2 ;10,125,140 B1 ;10,106,548 B2. (fms) (Entered: 02/14/2019)
14 February… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,296,753 B2 ;… 1 February 2018
1:18-cv-00192
835 Patent - Abbreviated New Drug Application(ANDA)
Defendant |
External link to document |
2019-03-15 |
128 |
Answer to Counterclaim |
Admitted.
17. U.S. Patent No. 10,106,548 (“the ’548 Patent”), on its face, is titled
“Crystalline…’753 Patent, the ’455
Patent, the ’382 Patent, the ’617 Patent, the ’090 Patent, the ’889 Patent, the…’753 Patent, the ’455 Patent, the ’382 Patent, the ’617 Patent, the ’090 Patent, the ’889 Patent,
the…’753 Patent, the ’455 Patent, the ’382 Patent, the ’617 Patent, the ’090 Patent, the ’889 Patent,
the…753
Patent, the ’455 Patent, the ’382 Patent, the ’617 Patent, the ’090 Patent, the ’889 Patent, the
|
External link to document |